EARNINGS PER SHARE. |
The
following tables compute basic and diluted earnings per share (in thousands, except per share data):
|
|
Three Months Ended June 30, 2021 |
|
|
|
Income Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
Net income attributed to Alto Ingredients, Inc. |
|
$ |
8,390 |
|
|
|
|
|
|
|
|
|
Less: Preferred stock dividends |
|
|
(315 |
) |
|
|
|
|
|
|
|
|
Basic income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income available to common stockholders |
|
$ |
8,075 |
|
|
|
71,260 |
|
|
$ |
0.11 |
|
Add: Dilutive instruments |
|
|
— |
|
|
|
669 |
|
|
|
|
|
Diluted income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income available to common stockholders |
|
$ |
8,075 |
|
|
|
71,929 |
|
|
$ |
0.11 |
|
|
|
Three Months Ended June 30, 2020 |
|
|
|
Income Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
Net income attributed to Alto Ingredients, Inc. |
|
$ |
14,964 |
|
|
|
|
|
|
|
|
|
Less: Preferred stock dividends |
|
|
(315 |
) |
|
|
|
|
|
|
|
|
Basic and diluted income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income available to common stockholders |
|
$ |
14,649 |
|
|
|
54,498 |
|
|
$ |
0.27 |
|
|
|
Six Months Ended June 30, 2021 |
|
|
|
Income Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
Net income attributed to Alto Ingredients, Inc. |
|
$ |
13,068 |
|
|
|
|
|
|
|
|
|
Less: Preferred stock dividends |
|
|
(627 |
) |
|
|
|
|
|
|
|
|
Basic income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income available to common stockholders |
|
$ |
12,441 |
|
|
|
70,808 |
|
|
$ |
0.18 |
|
Add: Dilutive instruments |
|
|
— |
|
|
|
1,153 |
|
|
|
|
|
Diluted income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income available to common stockholders |
|
$ |
12,441 |
|
|
|
71,961 |
|
|
$ |
0.17 |
|
|
|
Six Months Ended June 30, 2020 |
|
|
|
Loss Numerator |
|
|
Shares Denominator |
|
|
Per-Share Amount |
|
Net loss attributed to Alto Ingredients, Inc. |
|
$ |
(10,136 |
) |
|
|
|
|
|
|
|
|
Less: Preferred stock dividends |
|
|
(630 |
) |
|
|
|
|
|
|
|
|
Basic and diluted loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Loss available to common stockholders |
|
$ |
(10,766 |
) |
|
|
54,163 |
|
|
$ |
(0.20 |
) |
There
were an additional aggregate potentially dilutive weighted-average shares of 964,000 from convertible securities outstanding for the
three and six months ended June 30, 2021 and 2020. These securities were not considered in calculating diluted net income (loss) per
share for the three and six months ended June 30, 2021 and 2020, as their effect would have been anti-dilutive.
|